Dr Reddy's Laboratories jumped 5.01% to Rs 3,899.30 at 15:00 IST on BSE after consolidated net profit rose 13.67% to Rs 625.65 crore on 6.62% rise in total income to Rs 3770.25 crore in Q1 June 2015 over Q1 June 2014.
The company announced results during market hours today, 30 July 2015.
Meanwhile, the S&P BSE Sensex was up 147.48 points or 0.56% at 27,717.80.
On BSE, so far 97,207 shares were traded in the counter as against average daily volume of 16,138 shares in the past one quarter.
The stock hit a high of Rs 3,915 and a low of Rs 3,721.05 so far during the day. The stock had hit a record high of Rs 3,960 on 23 July 2015. The stock had hit a 52-week low of Rs 2,711.90 on 11 August 2014.
The stock had outperformed the market over the past one month till 29 July 2015, rising 5.46% compared with Sensex's 0.3% decline. The scrip had also outperformed the market in past one quarter, gaining 9.96% as against Sensex's 1.24% gain.
The large-cap pharma company has equity capital of Rs 85.28 crore. Face value per share is Rs 5.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
